Else Nutrition

LATEST MEDICINAL CANNABIS STOCK NEWS


Tilray Announces Pricing of Registered Offering of $150 Million of Unsecured Convertible Senior Notes

Last Trade: 1.86 -0.50 -21.19

Refinances a meaningful portion of our debt due in June 2024, extending maturity to 2027 and locking in lower fixed interest rate of 5.20%; Strengthens balance sheet with additional cash proceeds of $15 million or $37 million if over-allotment is exercised in full, to be used for strategic acquisitions and to pay down debt; Brings the Company’s current cash, cash equivalents and marketable securities on hand... Read more


Tilray Announces European Market Expansion in Italy

Last Trade: 1.86 -0.50 -21.19

MILAN, Italy, May 25, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that its medical cannabis division, Tilray Medical and FL Group, the Company’s subsidiary in Italy, have received authorization from Italy’s Ministry of Health to distribute three new medical... Read more


Body and Mind Markham Illinois Dispensary Grand Opening

Last Trade: 0.06 0.00 0.00

Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - May 25, 2023) - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM") an operations-driven multistate cannabis company, is pleased to announce the Grand Opening of the Body and Mind dispensary in Markham, Illinois. The Markham dispensary is conveniently located near the intersection of Highways I-57, I-294 and I-80 with over... Read more


Tilray Brands Announces Proposed Registered Offering of $150 Million of Convertible Senior Notes

Last Trade: 1.86 -0.50 -21.19

Convertible notes offer lower interest expense and fewer covenant restrictions than our non-convertible debt options due to the conversion option value and are less dilutive than issuance of common stock  A portion of the proceeds will be used to refinance existing debt LEAMINGTON, Ontario and NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX:... Read more


Trulieve Cannabis Announces Opening of Affiliated Medical Marijuana Dispensary in Limerick, PA

Last Trade: 4.21 -0.24 -5.39

New dispensary expands patient access to medical cannabis with ribbon cutting and pop-up event TALLAHASSEE, Fla., May 19, 2023 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the grand opening of a new Trulieve-affiliated medical marijuana dispensary in Limerick, PA. Located at 451 West... Read more


Skye Bioscience Begins Dosing Fifth of Six Cohorts in Phase 1 Clinical Trial of Novel CB1R Agonist

Last Trade: 0.01 -0.0001 -0.74

Skye advances multiple ascending dose arm of SBI-100 Ophthalmic Emulsion trial San Diego, California--(Newsfile Corp. - May 17, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma and ocular hypertension, has started dosing the second cohort of the multiple ascending dose ("MAD") arm of its... Read more


WEED is Proud to Announce the Appointment of Ms. Amanda Brunskill-Scott and Mrs. Nicole Breen as Members of our Board of Directors

Last Trade: 0.07 -0.01 -13.37

Ms. Brunskill-Scott will also take over the role of Managing Director and Corporate Secretary, while Mrs. Breen will take over the additional role and responsibilities of treasurer. TUCSON, AZ / ACCESSWIRE / May 17, 2023 / WEED Inc. (OTCQB:BUDZ), ("WEED" or the "Company") a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for... Read more


Cansortium: FLUENT Moves U.S. Headquarters to Tampa, Florida

Last Trade: 0.08 -0.001 -1.23

TAMPA, Fla., May 16, 2023 /CNW/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, announced it is moving its headquarters from Miami to the Westshore District of Tampa, Florida. Over the next four months, the Company plans to create more than 30 new jobs in administration, finance,... Read more


PharmaCielo Announces Shipment of Pharmaceutical Grade Cannabis Extract to Customer in South Africa

Last Trade: 0.13 -0.005 -3.60

Represents PharmaCielo's first shipment to South Africa, which has well-established export networks in the UK and Australia, and other potential markets, globally. Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 16, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and... Read more


Columbia Care Reports First Quarter 2023 Results

Last Trade: 0.44 -0.05 -9.42

Quarterly Revenue of $125 Million, an Increase of 1% YoY Quarterly Gross Profit of Over $47 Million, an Increase of 13% QoQ Quarterly Adjusted EBITDA1 of Over $16 Million and Adjusted EBITDA Margin1 of Over 13% NEW YORK / May 15, 2023 / Business Wire / Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators,... Read more


Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights

Last Trade: 0.33 0.0088 2.75

Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel™ in patients with Fragile X syndrome; topline results expected first-half 2024 $44.4 million in cash and cash equivalents at March 31, 2023; Cash runway to mid-year 2024 Proposal for a reverse stock split is on the agenda for June 13, 2023 annual meeting of stockholders to satisfy the minimum bid price requirement for continued... Read more


MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDA

Last Trade: 0.05 0.0011 2.13

TORONTO, May 15, 2023 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three months ended March 31, 2023. First Quarter 2023 – Select Highlights Progress Towards Profitability Achieved strongest EBITDA(1) in two years as... Read more


CV Sciences Reports First Quarter 2023 Financial Results

Last Trade: 0.04 -0.0003 -0.78

SAN DIEGO, May 15, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2023. First Quarter 2023 and Recent Financial and Operating Highlights Generated... Read more


Skye Bioscience Receives Positive Safety Review in First Multiple-Administration Cohort of Phase 1 Study of SBI-100 Ophthalmic Emulsion

Last Trade: 0.01 -0.0001 -0.74

San Diego, California--(Newsfile Corp. - May 15, 2023) -  Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reports that the safety review committee ("SRC") for its Phase 1 clinical trial of SBI-100 Ophthalmic Emulsion ("OE") has reviewed the data from the trial's fourth cohort and provided... Read more


Leafly Holdings Reports First Quarter 2023 Financial Results

Last Trade: 0.31 -0.03 -7.41

Delivered Q1 2023 revenue of $11.2 million Reported net loss of $5.4 million, an improvement from net loss of $19.4 million in Q1 2022; Delivered Q1 2023 adjusted EBITDA loss of $3.3 million, ahead of guidance Total Ending Retail Accounts grew to 5,702, up 5.2% over Q1 2022 SEATTLE / May 11, 2023 / Business Wire / Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis... Read more


Lexaria Bioscience: cGMP Manufacturing Complete for Lexaria's Upcoming U.S. Phase 1b Hypertension Clinical Trial

Last Trade: 0.78 0.03 4.48

DehydraTECH-CBD is currently unique in its evidenced superior power to reduce blood pressure over other oral CBD formulations. DehydraTECH-CBD has demonstrated exceptional safety and tolerability and a sustained decrease in blood pressure. KELOWNA, BC / ACCESSWIRE / May 11, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms... Read more


HEXO Announces Receipt of Interim Order in Respect of Arrangement With Tilray Brands

Last Trade: 1.02 -0.15 -12.82

GATINEAU, Québec / May 10, 2023 / Business Wire / HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the "Company") is pleased to announce that in connection with its previously announced arrangement agreement with Tilray Brands, Inc. (“Tilray”) for a transaction whereby Tilray has agreed to acquire all of the issued and outstanding common shares of the Company by way of court-approved plan of arrangement (the... Read more


Cronos Group Reports 2023 First Quarter Results

Last Trade: 1.77 -0.03 -1.67

Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in Canada increased 6% in Q1 2023 compared to Q1 2022; on a constant currency basis net revenue in Canada increased 14% in Q1 2023 compared to Q1 2022 Spinach® was top-10 in retail sales in the flower, edible, vape and pre-roll categories in Q1 2023 TORONTO, May 09, 2023... Read more


AREV Life Sciences Global Implements AI as a Driving Force to Identify Science Backed Compounds Synergistic to its Proprietary Extracts to Increase Efficacy of...

Last Trade: 0.10 0.00 0.00

Vancouver, BC - TheNewswire - May 9, 2023 - AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the Company”) AREV Life Sciences is pleased to announce it has completed its first phase of AI driven deductive research to identify the best complimentary natural compounds for use with its proprietary extracts and Combination Therapy in traditional medicine. Arev has written and refined an exclusive... Read more


Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Injection on a Paralyzed Goat

Last Trade: 0.14 0.00 0.00

HERZLIYA, Israel and CALGARY, Alberta, May 8, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a leading pharmaceutical and biotech company, is pleased to announce the successful treatment of Billy, a 4-year-old neutered male goat, with a liposomal-CBD injection in a pre-clinical trial. The innovative... Read more


SciSparc's Drug Discovery Joint Venture MitoCareX Bio Successfully Developed its Core Algorithm to allow suitable Modelling of Human Mitochondrial Carriers for...

Last Trade: 0.60 -0.02 -2.73

TEL AVIV, Israel, May 08, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that its joint venture MitoCareX Bio, which focuses on the discovery and development of potential drugs for cancers, rare diseases and other... Read more


SciSparc Completed Treatment of Last Patient Enrolled for its Phase IIa Clinical Trial for Alzheimer's Disease and Agitation

Last Trade: 0.60 -0.02 -2.73

The Company previously announced positive interim results from the trial meeting its primary endpoints TEL AVIV, Israel, May 02, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that the last patient enrolled in the Company's... Read more


Entourage Health Reports Fiscal Year 2022 Financial Results and Posts $54.5 Million in Total Revenues

Last Trade: 0.01 -0.0037 -20.56

Record net medical revenue of $17.4 million for 2022, representing 16% growth Entourage secured a 5% share of total sales, ranking them in the fourth spot of national pre-roll sales in 2022 Upsized credit facility with LiUNA Pension Fund Central and Eastern Canada (“LPF”) improves liquidity position TORONTO, May 01, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE)... Read more


Cansortium Reports Fourth Quarter and Full Year 2022 Results

Last Trade: 0.08 -0.001 -1.23

Q4 Revenue up 28% YoY to $23.5 Million; FY 2022 Revenue up 34% YoY to $87.7 Million  FY 2022 Cash from Operations up Significantly to $19.1 Million, Compared to Cash Used of $5.0 Million in FY 2021  MIAMI, May 1, 2023 /PRNewswire/ -  Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the Fluent™... Read more


PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2022

Last Trade: 0.13 -0.005 -3.60

During 2022, PharmaCielo made shipments to 23 clients in 9 countries, with continued growth expected for 2023. The Company's measured investments in revenue-generating sales channels resulted in revenues of $5.3 million in 2022, almost three-times more than the $1.9 million reported in 2021. Consistent progress on streamlining the business, to move toward profitability - 2022 SG&A expenses represent a 40%... Read more


Aurora Cannabis Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs

Last Trade: 0.54 -0.02 -3.55

EDMONTON, AB, April 28, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and a leading manufacturer and supplier of dried flower for medical patients worldwide, today announced the expansion of its portfolio in Germany with the launch of two new cannabis flower products for patients. Pedanios 27/1 FRG CA and Pedanios 29/1 SRD... Read more


Trulieve Cannabis Announces Georgia's First Medical Cannabis Dispensary

Last Trade: 4.21 -0.24 -5.39

New dispensary in Macon provides first patient access to medical cannabis in the state TALLAHASSEE, Fla., April 27, 2023 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the grand opening of Georgia's first medical cannabis dispensary in Macon. The new dispensary will be open 10 AM - 7... Read more


Skye Bioscience Begins Dosing Phase 1 Fourth Cohort in Clinical Trial of Novel CB1R Agonist

Last Trade: 0.01 -0.0001 -0.74

Skye progresses to multiple ascending dose arm of SBI-100 Ophthalmic Emulsion trial after completing single ascending dose arm P1 dosing of novel cannabinoid derivative planned for completion in Q2, with data reporting in Q3 San Diego, California--(Newsfile Corp. - April 27, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic... Read more


Allied Corp Signs Joint Venture With Blueberries Medical to Expand Product Offering and Bring Derivative Products to Global Markets

Last Trade: 0.01 0.00 0.00

KELOWNA, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID), a leading cannabis cultivator based in Colombia and one of the few to have executed on international exports, is pleased to announce that it has signed a joint venture agreement with Blueberries Medical Corp. (“Blueberries") (OTC:BBRRF), one of the largest extraction companies in Colombia, to... Read more


Aurora Cannabis Introduces Fresh Innovation for Spring

Last Trade: 0.54 -0.02 -3.55

New additions to lineup include two original cultivars from Aurora's breeding program, strain-specific gummies, aromatic vapes and terpy diamonds & sauce EDMONTON, AB, April 25, 2023 /CNW/ - Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced a fresh lineup of innovative products. Coming soon to patients at Aurora Medical and to consumers at retail... Read more


Cronos Group Releases Cannabinoid Life Cycle Study Highlighting its Sustainable Fermentation Practices

Last Trade: 1.77 -0.03 -1.67

TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today, in honor of Earth Day, released a Sustainability Study, which outlines the benefits of using fermentation manufacturing methods for cannabinoid production over the impact of traditional methods of cannabis extraction, which leverage indoor cultivation methods*. The third-party reviewed... Read more


Khiron Life Sciences Completes First Phase of Business Optimization

Last Trade: 0.05 -0.0028 -5.75

First phase of optimization was focused on streamlining Colombian operations, resulting in a moving forward annualized cost reduction of CAD 5.0 million, representing overall cost savings of more than 45% compared to 20221. Khiron has completed the wind down of its Colombian cultivation and extraction activities, to focus on its clinics business and its high-margin B2C medical cannabis model in... Read more


Tilray Brands: Celebrate 420 with Good Supply!

Last Trade: 1.86 -0.50 -21.19

TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, announced today the launch of their latest product lineup from its best-selling Canadian cannabis brand, Good Supply1. In celebration of this year’s upcoming 420 holiday, Good Supply is introducing a range of new products,... Read more


PharmaCielo Announces Strategic Partnership with CANNPRISMA to Supply EU-GMP Certified Dried Flower to the European Medicinal Cannabis Market

Last Trade: 0.13 -0.005 -3.60

Will bring unique high-THC Colombian strains owned by PharmaCielo to Europe for the first time. Combines PharmaCielo's expertise in producing premium medicinal cannabis products, with CANNPRISMA's conversion capabilities, to bring patients in Europe the highest quality high-THC flower product currently available in the market. Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - April 19, 2023) -... Read more


Columbia Care Continues Momentum in Virginia with Opening of Ninth Dispensary ahead of 4/20 Holiday

Last Trade: 0.44 -0.05 -9.42

Cannabist Norfolk is Company’s 35th Cannabist Location and 85th Active Dispensary Nationwide NEW YORK / Apr 19, 2023 / Business Wire / Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced it has opened its ninth of twelve planned... Read more


Innocan Pharma Reports Annual 2022 Results with USD 2.6M in Revenue

Last Trade: 0.14 0.00 0.00

HERZLIYA, Israel and CALGARY, Alberta, April 18, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a proprietary IP portfolio, is pleased to report its audited financial results for the year ended December 31,2022. Additional information... Read more


Schwazze Signs Definitive Documents to Acquire One Medical Retail Dispensary in Denver, Colorado, from Standing Akimbo

Last Trade: 1.01 -0.02 -2.03

DENVER, Colo., April 18, 2023 /CNW/ - Medicine Man Technologies operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), announced that it has signed definitive documents to acquire certain assets of Standing Akimbo LLC ("Standing Akimbo"). The proposed transaction includes the medical cannabis dispensary located at 3801 Jason Street in Denver, Colorado. This acquisition... Read more


Incannex Healthcare Appoints QPS to Advance CannQuit-N™ (Nicotine), CannQuit-O™ (Opioid) and Renecann™ Products in the USA and EU

Last Trade: 2.02 -0.01 -0.63

MELBOURNE, Australia, April 14, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet medical needs, is pleased to announce that is has appointed Quest Pharmaceutical Services (‘QPS’) to provide regulatory advice and manage clinical... Read more


MediPharm Labs Provides Update on VIVO Integration and Board Appointee

Last Trade: 0.05 0.0011 2.13

MediPharm Labs begins restructuring immediately following completion of its acquisition of VIVO and reiterates confidence in $7 to 9M of projected annualized synergies. (1)(2)(3)(4) MediPharm Labs appoints Michael Bumby, former Chief Financial Officer of VIVO, to the Board of Directors of MediPharm. BARRIE, ON, April 13, 2023 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm... Read more


Aurora Cannabis and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients

Last Trade: 0.54 -0.02 -3.55

Available through MedReleaf's Concession Scheme, doctors and patients will have more freedom in choosing their cannabis medication EDMONTON, AB, April 12, 2023 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and MedReleaf Australia today announced the launch of IndiMed Tempo 26, a range of new higher THC dried cannabis products for qualified patients... Read more

COPYRIGHT ©2022 GREEN STOCK NEWS